Open Access

Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy

  • Authors:
    • Shibo Wang
    • Jing Han
    • Lei Cheng
    • Nengpeng Li
  • View Affiliations

  • Published online on: July 17, 2017     https://doi.org/10.3892/etm.2017.4796
  • Pages: 2517-2520
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

This study sought to investigate the risk factors for cerebral hyperperfusion syndrome (CHS) after carotid artery interventional therapy, and to explore potential preventive measures. Three hundred and eighty-two patients treated with carotid artery stenting at the Huanhu Hospital (Tianjin, China) between January 2010 and January 2016 were divided into CHS and non-CHS groups. A retrospective analysis of patient clinical data was made. The CHS group had more patients presenting coronary heart disease, diabetes, progressive neurological disease and transient recurrent cerebral hemorrhage than the non-CHS group. More patients in the CHS group presented stenosis of the internal carotid artery siphon. More CHS group patients showed plaque formation extending >3 cm to the distal end of the internal carotid artery. Finally, more CHS group patients had pressure gradients >60 mmHg (p<0.05). Logistics regression analysis showed that preoperative diabetes mellitus and carotid pressure gradient ≥60 mmHg were independent risk factors for CHS (p<0.05). The ROC curve of carotid pressure gradients ≥60 mmHg were made to predict CHS, with the area under curve being 0.949 (p<0.05). The best cut-off value was 60 mmHg. Therefore, preoperative diabetes and a carotid pressure gradient ≥60 mmHg are risk factors for CHS, and these indicators need to be examined prior to operation.

Related Articles

Journal Cover

September-2017
Volume 14 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang S, Han J, Cheng L and Li N: Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy. Exp Ther Med 14: 2517-2520, 2017
APA
Wang, S., Han, J., Cheng, L., & Li, N. (2017). Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy. Experimental and Therapeutic Medicine, 14, 2517-2520. https://doi.org/10.3892/etm.2017.4796
MLA
Wang, S., Han, J., Cheng, L., Li, N."Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy". Experimental and Therapeutic Medicine 14.3 (2017): 2517-2520.
Chicago
Wang, S., Han, J., Cheng, L., Li, N."Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy". Experimental and Therapeutic Medicine 14, no. 3 (2017): 2517-2520. https://doi.org/10.3892/etm.2017.4796